Epigenomic, transcriptomic, and proteomic characterization of breast cancer cell line reference samples
- PMID: 41539304
- PMCID: PMC12853167
- DOI: 10.1016/j.crmeth.2025.101276
Epigenomic, transcriptomic, and proteomic characterization of breast cancer cell line reference samples
Abstract
Next-generation sequencing requires accuracy, reproducibility, and standardized reference materials. The Sequencing Quality Control (SEQC-2) multicenter studies on paired breast cancer and B cell lines generated extensive genomic datasets, but integrated epigenomic and proteomic references remain limited. Here, we performed Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq), Methyl-seq, RNA sequencing (RNA-seq), and proteomic profiling to establish comprehensive multi-omics reference materials. We identified >7,700 protein groups, with 95% of genes encoding a single peptide isoform. Protein expression from CpG island (CGI)-overlapping transcripts was higher than non-CGI transcripts in both cell lines. Certain SNVs were incorporated into mutated peptides. Chromatin accessibility was regulated by CG density: CG-rich regions showed lower methylation, greater accessibility, and higher gene/protein expression, whereas CG-poor regions exhibited higher methylation, reduced accessibility, and cell line-specific expression patterns. These datasets provide well-defined genomic, epigenomic, transcriptomic, and proteomic characterizations that can serve as benchmarks for validating omics assays and bioinformatics methods, offering a valuable community resource.
Keywords: CP: genetics; epigenomics; proteomics; transcriptomics.
Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests A.F. is an employee of Takara Bio USA, Inc., and W.J. is an employee of IQVIA Laboratories Genomics. The views presented in this article do not necessarily reflect the current or future opinion or policy of the US Food and Drug Administration. Any mention of commercial products is for clarification and not intended as an endorsement.
Figures
Update of
-
Epigenomic, transcriptomic and proteomic characterizations of reference samples.bioRxiv [Preprint]. 2024 Sep 17:2024.09.09.612110. doi: 10.1101/2024.09.09.612110. bioRxiv. 2024. Update in: Cell Rep Methods. 2026 Jan 26;6(1):101276. doi: 10.1016/j.crmeth.2025.101276. PMID: 39314461 Free PMC article. Updated. Preprint.
References
-
- Fang L.T., Zhu B., Zhao Y., Chen W., Yang Z., Kerrigan L., Langenbach K., de Mars M., Lu C., Idler K., et al. Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing. Nat. Biotechnol. 2021;39:1151–1160. doi: 10.1038/s41587-021-00993-6. - DOI - PMC - PubMed
-
- Xiao C., Chen Z., Chen W., Padilla C., Colgan M., Wu W., Fang L.T., Liu T., Yang Y., Schneider V., et al. Personalized genome assembly for accurate cancer somatic mutation discovery using tumor-normal paired reference samples. Genome Biol. 2022;23:237. doi: 10.1186/s13059-022-02803-x. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
